| Budget Amount *help |
¥18,850,000 (Direct Cost: ¥14,500,000、Indirect Cost: ¥4,350,000)
Fiscal Year 2015: ¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2014: ¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2013: ¥8,060,000 (Direct Cost: ¥6,200,000、Indirect Cost: ¥1,860,000)
|
|---|
| Outline of Final Research Achievements |
In this study, we analyze serum from cancer patients by using gas chromatograph mass spectrometry and liquid chromatograph mass spectrometry, and then validated the possibility for the cancer profiling diagnosis system based on the alterations in the levels of blood metabolites. We established the four kinds of the analyzing platform for blood metabolites, and then analyzed serum from cancer patients by using these platforms. As a result, we could find the candidates for metabolite biomarkers, and furthermore could suggested the new diagnosis procedure called ‘2-phase screening’.
|
